This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The hiring of a former top FDA official amplifies "revolving door" criticism at ...
Granules shelled out a reported 20 million Swiss francs ($22.3 million) to acqui...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug con...
Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendi...
MONDAY, Feb. 24, 2025 -- In the United States, the COVID-19 pandemic was associ...
MONDAY, Feb. 24, 2025 -- The use of multiple muscle-building supplements is ass...
MONDAY, Feb. 24, 2025 -- The highest risk for epilepsy after neonatal seizures ...
MONDAY, Feb. 24, 2025 -- Compared with manual screening, an artificial intellig...
MONDAY, Feb. 24, 2025 -- Screen time such as social media and video games may b...
MONDAY, Feb. 24, 2025 -- The long-term outcomes of sleeve gastrectomy (SG) and ...
MONDAY, Feb. 24, 2025 -- Smoking and high-intensity smoking are associated with...
MONDAY, Feb. 24, 2025 -- For patients with stage III colon cancer participating...
Cavazzoni stepped down from her role as head of the FDA’s main drug review offic...
Veterinary medicines European public assessment report (EPAR): Poulvac Procerta ...
After hundreds of FDA employees were suddenly laid off last weekend, including d...
Veterinary medicines European public assessment report (EPAR): Icthiovac ERM, in...
The United States has joined a WHO-led flu vaccine meeting, despite the Trump ad...
Detailed results presented at a medical congress help reinforce analyst expectat...
List of medicinal products under additional monitoring
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagen...
After leaving the FDA, where she served as director of the Center for Drug Evalu...
Pfizer has teamed up with Summit Therapeutics to assess whether one of the indus...
Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Da...